EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review

Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël Hiligsmann iD

PharmacoEconomics · 2023

DOI: 10.1007/s40273-022-01239-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PharmacoEconomics, 2023. Verfasst von Nannan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200 MD, Maastricht, T…. Hauptthemen laut MEDLINE: Osteoporosis, Postmenopausal, Osteoporosis, Osteoporotic Fractures, Bone Density Conservation Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Radius Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteoporosis is often considered to be a disease of women. Over the last few years, owing to the increasing clinical and economic burden, the awareness and imperative for identifying and managing osteoporosis in men have increased substantially. With the approval of agents to treat men with osteoporosis, more economic evaluations have been conducted to assess the potential economic benefits of these interventions. Despite this concern, there is no specific overview of cost-effectiveness analyses for the treatment of osteoporosis in men. OBJECTIVES: This study aims (1) to systematically review economic evaluations of interventions for osteoporosis in men; (2) to critically appraise the quality of included studies and the source of model input data; and (3) to investigate the comparability of results for studies including both men and women. METHODS: A literature search mainly using MEDLINE (via Ovid) and Embase databases was undertaken to identify original articles published between 1 January, 2000 and 30 June, 2022. Studies that assessed the cost effectiveness of interventions for osteoporosis in men were included. The Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases and the International Osteoporosis Foundation osteoporosis-specific guideline was used to assess the quality of design, conduct, and reporting of included studies. RESULTS: Of 2973 articles identified, 25 studies fulfilled the inclusion criteria, classified into economic evaluations of active drugs (n = 8) or nutritional supplements (n = 4), intervention thresholds (n = 5), screening strategies (n = 6), and post-fracture care programs (n = 2). Most studies were conducted in European countries (n = 15), followed by North America (n = 9). Bisphosphonates (namely alendronate) and nutritional supplements were shown to be generally cost effective compared with no treatment in men over 60 years of age with osteoporosis or prior fractures. Two other studies suggested that denosumab was cost effective in men aged 75 years and older with osteoporosis compared with bisphosphates and teriparatide. Intervention thresholds at which bisphosphonates were found to be cost effective varied among studies with a 10-year probability of a major osteoporotic fracture that ranged from 8.9 to 34.2% for different age categories. A few studies suggested cost effectiveness of screening strategies and post-fracture care programs in men. Similar findings regarding the cost effectiveness of drugs and intervention thresholds in women and men were captured, with slightly greater incremental cost-effectiveness ratios in men. The quality of the studies included had an average score of 18.8 out of 25 (range 13-23.5). Hip fracture incidence and mortality risk were mainly derived from studies in men, while fracture cost, treatment efficacy, and disutility were commonly derived from studies in women or studies combining both sexes. CONCLUSIONS: Anti-osteoporosis drugs and nutritional supplements are generally cost effective in men with osteoporosis. Screening strategies and post-fracture care programs also showed economic benefits for men. Cost-effectiveness and intervention thresholds were generally similar in studies conducted in both men and women, with slightly greater incremental cost-effectiveness ratios in men.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteoporosis, PostmenopausalOsteoporosisOsteoporotic FracturesBone Density Conservation AgentsMaleFemaleHumansMiddle AgedAgedCost-Effectiveness AnalysisDiphosphonatesCost-Benefit Analysis

Substanzen

DiphosphonatesBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200 MD, Maastricht, The Netherlands.
  • WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium.
  • Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
  • Division of Endocrinology, Diabetes and Metabolism, Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Department of Medicine, University of California at Davis, School of Medicine, Sacramento, CA, USA.
  • Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

ORCID-Profile: Mickaël Hiligsmann

Förderung

  • Radius Health

Zitieren

APA

Li, N., Beaudart, C., Cauley, J. A., Ing, S. W., Lane, N. E., Reginster, J. Y., Silverman, S., Singer, A. J., & Hiligsmann, M. (2023). Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics. https://doi.org/10.1007/s40273-022-01239-2

Vancouver

Li N, Beaudart C, Cauley JA, Ing SW, Lane NE, Reginster JY, et al. Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics. 2023. doi:10.1007/s40273-022-01239-2

BibTeX
@article{Li2023,
  author = {Li, Nannan and Beaudart, Charlotte and Cauley, Jane A and Ing, Steven W and Lane, Nancy E and Reginster, Jean-Yves and Silverman, Stuart and Singer, Andrea J and Hiligsmann, Mickaël},
  title = {Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review},
  journal = {PharmacoEconomics},
  year = {2023},
  doi = {10.1007/s40273-022-01239-2}
}
Kostenlos starten →